{"id":741,"date":"2020-08-26T09:31:37","date_gmt":"2020-08-26T09:31:37","guid":{"rendered":"https:\/\/clinlabint.3wstaging.nl\/raman-spectroscopy-poised-to-make-thyroid-cancer-diagnosis-less-invasive\/"},"modified":"2021-01-08T11:08:10","modified_gmt":"2021-01-08T11:08:10","slug":"raman-spectroscopy-poised-to-make-thyroid-cancer-diagnosis-less-invasive","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/raman-spectroscopy-poised-to-make-thyroid-cancer-diagnosis-less-invasive\/","title":{"rendered":"Raman spectroscopy poised to make thyroid cancer diagnosis less invasive"},"content":{"rendered":"

Researchers have demonstrated that an optical technique known as Raman spectroscopy can be used to differentiate between benign and cancerous thyroid cells. The new study shows Raman spectroscopy\u2019s potential as a tool to improve the diagnosis of thyroid cancer, which is the ninth most common cancer with more than 50,000 new cases diagnosed in the United States each year.
\n\u201cOur encouraging results show that Raman spectroscopy could be developed into a new optical modality that can help avoid invasive procedures used to diagnose thyroid cancer by providing biochemical information that isn\u2019t currently accessible,\u201d said James W. Chan from the University of California, Davis, U.S.A. \u201cThis could have a major impact in the field of pathology and could lead to new ways to diagnose other diseases.\u201d
\nA lump \u2014 or nodule \u2014 in the neck is a common symptom of thyroid cancer. However, most thyroid nodules aren\u2019t cancerous. Ultrasound-guided fine needle aspiration biopsies are typically used to check for cancer by inserting a thin needle into the nodule to obtain cells that are prepared on a microscope slide, stained and analysed by a pathologist. For about 15 to 30 percent of cases, the pathologist cannot determine whether cells acquired from the biopsy are benign or malignant. For these cases, a surgical procedure known as a thyroidectomy is required to remove tissue, which provides more information for a more accurate diagnosis. The researchers turned to Raman spectroscopy as a possible solution because it is a non-invasive technique that requires no sample preparation or staining to determine subtle differences in the molecular composition of complex samples such as cells.
\u201cWe would like to use Raman spectroscopy to improve the pathologist\u2019s analysis of the cells obtained with fine needle aspiration to reduce the number of thyroidectomies necessary,\u201d said Chan. \u201cThis would both minimize surgical complications and reduce healthcare costs.\u201d
\nFor the new study, the researchers used a line-scan Raman microscope that allowed them to rapidly acquire Raman signals from an entire cell volume. This allowed them to more accurately capture the chemical composition of entire cells compared to other approaches that acquire a Raman spectrum from only part of a cell\u2019s volume. Multivariate statistical methods and classification methods were then used to analyse the Raman data and classify the cells in an objective, unbiased manner.
\nThe researchers applied this Raman spectroscopy approach to individual cells isolated from 10 patient thyroid nodules diagnosed as benign or cancerous. The data analysis identified unique spectral differences that could distinguish cancerous cells from benign with 97 percent diagnostic accuracy. They also showed that other subtypes could be identified by their spectral differences.
\n\u201cThese preliminary results are exciting because they involve single cells from human clinical samples, but more work will need to be done to take this from a research project to final clinical use,\u201d said Chan.
\nThe Optical Society (OSA)\nhttps:\/\/tinyurl.com\/y6hw35z8<\/link>\n","protected":false},"excerpt":{"rendered":"

Researchers have demonstrated that an optical technique known as Raman spectroscopy can be used to differentiate between benign and cancerous thyroid cells. The new study shows Raman spectroscopy\u2019s potential as a tool to improve the diagnosis of thyroid cancer, which is the ninth most common cancer with more than 50,000 new cases diagnosed in the […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[35],"tags":[],"_links":{"self":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/741"}],"collection":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/comments?post=741"}],"version-history":[{"count":0,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/741\/revisions"}],"wp:attachment":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media?parent=741"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/categories?post=741"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/tags?post=741"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}